Abstract
5536Background: STM 434 is an ACVR2B soluble receptor ligand trap that inhibits activin-A, a protein in the TGF-beta superfamily implicated in tumor growth, angiogenesis and immune modulation. Muta...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
